HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Targets for low-density lipoprotein cholesterol levels in patients with stable coronary heart disease: where are we now after the "treating to new targets" (TNT) trial?

AuthorsEvagelos N Liberopoulos, Vasilios G Athyros, Moses S Elisaf, Dimitri P Mikhailidis
JournalHellenic journal of cardiology : HJC = Hellenike kardiologike epitheorese (Hellenic J Cardiol) 2005 May-Jun Vol. 46 Issue 3 Pg. 161-4 ISSN: 1109-9666 [Print] Netherlands
PMID15981550 (Publication Type: Editorial)
Chemical References
  • Anticholesteremic Agents
  • Azetidines
  • Heptanoic Acids
  • Lipoproteins, LDL
  • Pyrroles
  • Atorvastatin
  • Ezetimibe
Topics
  • Anticholesteremic Agents (therapeutic use)
  • Atorvastatin
  • Azetidines (therapeutic use)
  • Coronary Disease (blood, prevention & control)
  • Drug Therapy, Combination
  • Ezetimibe
  • Heptanoic Acids (therapeutic use)
  • Humans
  • Lipoproteins, LDL (blood, drug effects)
  • Pyrroles (therapeutic use)
  • Randomized Controlled Trials as Topic (methods)
  • Treatment Outcome

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: